Brain natriuretic peptide inhibits hypoxic pulmonary hypertension in rats

Journal of Applied Physiology

Volumn 84, Issue 5, 1998, Pages 1646-1652

  Klinger, James R ^a,b   Warburton, Rod R ^a   Pietras, Linda ^a   Hill, Nicholas S ^a  

^a BROWN UNIVERSITY   (United States)

^b RHODE ISLAND HOSPITAL   (United States)

Author keywords

Anoxia; Atrial natriuretic peptide; Brain natriuretic peptide; Pulmonary circulation

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE;

ANIMAL EXPERIMENT; ARTICLE; CARDIOPULMONARY HEMODYNAMICS; CARDIOVASCULAR AUTOREGULATION; CONTROLLED STUDY; HEART RIGHT VENTRICLE PRESSURE; HUMAN; HYPOXIA; LUNG BLOOD FLOW; MALE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RAT;

EID: 0031978887     PISSN: 87507587     EISSN: None     Source Type: Journal    
DOI: 10.1152/jappl.1998.84.5.1646     Document Type: Article

References (28)

1. Aburaya, M., N. Minamino, J. Hino, K. Kangawa, and H. Matsuo. Distribution and molecular forms of brain natriuretic peptide in the central nervous system, heart and peripheral tissue of rat. Biochem. Biophys. Res. Commun. 165: 880-887, 1989.
2. Adnot, S., P. E. Chabrier, C. Brun-Buisson, I. Viossat, and P. Braquet. Atrial natriuretic factor attenuates the pulmonary pressor response to hypoxia. J. Appl. Physiol. 65: 1975-1983, 1988.
3. Arjona, A. A., C. A. Hsu, D. S. Wrenn, and N. S. Hill. Effects of natriuretic peptides on vascular smooth muscle cells derived from different vascular beds. Gen. Pharmacol. 28: 382-392, 1997.
4. Chang, M. S., D. G. Lowe, M. Lewis, R. Hellmiss, E. Chen, and D. V. Goeddel. Differential activation by atrial and brain natriuretic peptides of two different receptor guanylate cyclases. Nature 341: 68-72, 1989.
5. Florkowski, C. M., A. M. Richards, E. A. Espiner, T. G. Yandle, and C. Frampton. Renal, endocrine, and hemodynamic interactions of atrial and brain natriuretic peptides in normal men. Am. J. Physiol. 266 (Regulatory Integrative Comp. Physiol. 35): R1244-R1250, 1994.
6. Furaya, M., K. Aisaka, T. Miyazaki, N. Honbou, K. Kawashima, T. Ohno, S. Tanaka, N. Minamino, K. Kangawa, and H. Matsuo. C-type natriuretic peptide inhibits intimai thickening after vascular injury. Biochem. Biophys. Res. Commun. 193: 248-253, 1993.
7. Garbers, D. L., and D. G. Lowe. Guanylyl cyclase receptors. J. Biol. Chem. 269: 30741-30744, 1994.
8. Hama, N., H. Itoh, G. Shirakami, O. Nakagawa, S.-I. Suga, Y. Ogawa, I. Masuda, K. Nakanishi, T. Yoshimasa, Y. Hashimoto, M. Yamaguchi, R. Hori, H. Yasue, and K. Nakao. Rapid ventricular induction of brain natriuretic peptide gene expression in experimental acute myocardial infarction. Circulation 92: 1558-1564, 1995.
9. Hill, N. S., J. R. Klinger, R. R. Warburton, L. Pietras, and D. S. Wrenn. Brain natriuretic peptide: possible role in the modulation of hypoxic pulmonary hypertension. Am. J. Physiol. 266 (Lung Cell. Mol. Physiol. 10): L308-L315, 1994.
10. Hino, J., H. Tateyama, N. Minamino, K. Kangawa, and H. Matsuo. Isolation and identification of human brain natriuretic peptides in cardiac atrium. Biochem. Biophys. Res. Commun. 167: 693-700, 1990.
11. Hunt, P. J., E. A. Espiner, M. G. Nicholls, A. M. Richards, and T. G. Yandle. Differing biological effects of equimolar atrial and brain natriuretic peptide infusion in normal man. J. Clin. Endocrinol. Metab. 81: 3871-3876, 1996.
12. Jin, H., R.-H. Yang, Y.-F. Chen, R. M. Jackson, and S. Oparil. Atrial natriuretic peptide attenuates the development of pulmonary hypertension in rats adapted to chronic hypoxia. J. Clin. Invest. 85: 115-120, 1990.
13. Klinger, J. R., R. D. Petit, L. A. Curtin, R. R. Warburton, D. S. Wrenn, M. E. Steinhelper, L. J. Field, and N. S. Hill. Cardiopulmonary responses to chronic hypoxia in transgenic mice that overexpress ANP. J. Appl. Physiol. 75: 198-205, 1993.
14. Koller, K. J., and D. V. Goeddel. Molecular biology of the natriuretic peptides and their receptors. Circulation 86: 1081-1088, 1992.
15. McKenzie, J. C., I. Tanaka, T. Inagami, K. S. Misono, and R. M. Klein. Alterations in atrial and plasma atrial natriuretic factor (ANF) content during development of hypoxia-induced pulmonary hypertension in the rat. Proc. Soc. Exp. Biol. Med. 181: 459-463, 1986.
16. McKenzie, J. C., K. B. Kelley, E. M. Merisko-Liversidge, J. Kennedy, and R. M. Klein. Developmental pattern of ventricular atrial natriuretic peptide (ANP) expression in chronically hypoxic rats as an indicator of the hypertrophic process. J. Mol. Cell. Cardiol. 26: 753-767, 1994.
17. Meyrick, B., and L. Reid. The effect of continued hypoxia on rat pulmonary arterial circulation. Lab. Invest. 38: 188-200, 1978.
18. Lang, C. C., A. J. Choy, and A. D. Struthers. Atrial and brain natriuretic peptides: a dual natriuretic peptide system potentially involved in circulatory homeostasis. Clin. Sci. (Colch.) 83: 519-527, 1992.
19. Li, H., S. Oparil, Q.-C. Meng, T. S. Elton, and Y.-F. Chen. Selective downregulation of ANP-clearance-receptor gene expression in lung of rats adapted to hypoxia. Am. J. Physiol. 268 (Lung Cell. Mol. Physiol. 12): L328-L335, 1995.
20. Mukoyama, M., K. Nakao, K. Hosoda, K.-I. Suga, Y. Saito, and Y. Ogawa. Brain natriuretic peptide as a novel cardiac hormone in humans. J. Clin. Invest. 87: 1402-1412, 1991.
21. Nakagawa, O., Y. Ogawa, H. Itoh, S.-I. Suga, Y. Komatsu, I. Kishimoto, K. Nishino, T. Yoshimasa, and K. Nakao. Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy. J. Clin. Invest. 96: 1280-1287, 1995.
22. Nazario, B., R.-M. Hu, A. Pedram, B. Prins, and E. R. Levin. Atrial and brain natriuretic peptides stimulate the production and secretion of C-type natriuretic peptide from bovine aortic endothelial cells. J. Clin. Invest. 95: 1151-1157, 1995.
23. Ogawa, Y., K. Nakao, M. Mukoyama, K. Hosoda, G. Shirakami, H. Arai, Y. Saito, S.-I. Suga, M. Jougasaki, and H. Imura. Natriuretic peptides as cardiac hormones in normotensive and spontaneously hypertensive rats. Circ. Res. 69: 491-500, 1991.
24. Raffestin, B., M. Levame, S. Eddahibi, I. Viossat, P. Braquet, P. E. Chabrier, M. Cantin, and S. Adnot. Pulmonary vasodilatory action of endogenous atrial natriuretic factor in rats with hypoxic pulmonary hypertension: effects of monoclonal atrial natriuretic factor antibody. Circ. Res. 70: 184-192, 1992.
25. Stockman, P. T., D. H. Will, S. D. Sides, S. R. Brunnert, G. D. Wilner, K. M. Leahy, R. C. Wiegand, and P. Needleman. Reversible induction of right ventricular atriopeptin synthesis in hypertrophy due to hypoxia. Circ. Res. 63: 207-213, 1988.
26. Sudoh, T., K. Kangawa, N. Minamino, and H. Matsuo. A new natriuretic peptide in porcine brain. Nature 332: 78-81, 1988.
27. Volpe, M. R., E. Sosa, F. B. Muller, M. J. F. Camargo, N. Glorioso, J. H. Laragh, T. Maack, and S. A. Atlas. Differing hemodynamic responses to atrial natriuretic factor in two models of hypertension. Am. J. Physiol. 250 (Heart Circ. Physiol. 19): H871-H878, 1986.
28. Zhao, L., J. M. B. Hughes, and R. J. D. Winter. Effects of natriuretic peptides and neutral endopeptidase 24.11 inhibition in isolated perfused rat lung. Am. Rev. Respir. Dis. 146: 1198-1201, 1992.